Zum Hauptinhalt springen
Hochschulbibliothek Niederrhein

Suchergebnisse

Katalog

Mehr
30 Treffer

Suchmaske

Suchtipp für den Bereich Mehr: Wörter werden automatisch mit UND verknüpft. Eine ODER-Verknüpfung erreicht man mit dem Zeichen "|", eine NICHT-Verknüpfung mit einem "-" (Minus) vor einem Wort. Anführungszeichen ermöglichen eine Phrasensuche.
Beispiele: (burg | schloss) -mittelalter, "berufliche bildung"

Suchergebnisse einschränken oder erweitern

Aktive Suchfilter

Erscheinungszeitraum

Mehr Treffer

Weniger Treffer

Thema

Sprache

Inhaltsanbieter

30 Treffer

Sortierung: 
  1. Detailansicht für Treffer 1 öffnen
    Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical Trial
    Ihm, Sang-Hyun ; Seong Mi Park ; et al.
    In: Clinical Therapeutics, Jg. 39 (2017-08-01), S. 1628-1638
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  2. Detailansicht für Treffer 2 öffnen
    Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial
    Sang Hong Baek ; Byung Hee Oh ; et al.
    In: Clinical Therapeutics, Jg. 37 (2015-08-01), S. 1726-1739
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  3. Detailansicht für Treffer 3 öffnen
    A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia
    Tae Ho Park ; Si Wan Choi ; et al.
    In: Clinical therapeutics, Jg. 39 (2017-08-08), Heft 12
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  4. Detailansicht für Treffer 4 öffnen
    Evaluation of the Efficacy and Tolerability of Fixed-Dose Combination Therapy of Azilsartan and Amlodipine Besylate in Japanese Patients With Grade I to II Essential Hypertension
    Kagawa, Tomoya ; Rakugi, Hiromi ; et al.
    In: Clinical Therapeutics, Jg. 36 (2014-05-01), S. 711-721
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  5. Detailansicht für Treffer 5 öffnen
    A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy
    Ki Chul Sung ; Shin, Jinho ; et al.
    In: Clinical therapeutics, Jg. 38 (2016-03-14), Heft 10
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  6. Detailansicht für Treffer 6 öffnen
    A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension
    Tae Joon Cha ; Gwang Soo Cha ; et al.
    In: Clinical therapeutics, Jg. 38 (2016-01-07), Heft 6
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  7. Detailansicht für Treffer 7 öffnen
    Evaluation of the Efficacy and Tolerability of Combination Therapy With Candesartan Cilexetil and Amlodipine Besilate Compared With Candesartan Cilexetil Monotherapy and Amlodipine Besilate Monotherapy in Japanese Patients With Mild-to-Moderate Essential Hypertension: A Multicenter, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
    Rakugi, Hiromi ; Totsuka, Nobuo ; et al.
    In: Clinical Therapeutics, Jg. 34 (2012-04-01), S. 838-848
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  8. Detailansicht für Treffer 8 öffnen
    Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in japanese patients with essential hypertension: Additional results from the REZALT study
    Shimada, Kazuyuki ; Saruta, Takao ; et al.
    In: Clinical Therapeutics, Jg. 32 (2010-05-01), S. 861-881
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  9. Detailansicht für Treffer 9 öffnen
    Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study
    Ki Chul Sung ; Tack Jong Hong ; et al.
    In: Clinical Therapeutics, Jg. 40 (2018), S. 50-50
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  10. Detailansicht für Treffer 10 öffnen
    Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension
    Pospiech, Rainer ; Jin, James ; et al.
    In: Clinical Therapeutics, Jg. 29 (2007-04-01), S. 563-580
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  11. Detailansicht für Treffer 11 öffnen
    A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension
    Lyle, Paulette A. ; Feig, Peter U. ; et al.
    In: Clinical Therapeutics, Jg. 28 (2006-10-01), S. 1639-1648
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  12. Detailansicht für Treffer 12 öffnen
    Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: A two-year, randomized, placebo-controlled study
    Yi Jen Chen ; Tomlinson, Brian ; et al.
    In: Clinical Therapeutics, Jg. 25 (2003-11-01), S. 2797-2808
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  13. Detailansicht für Treffer 13 öffnen
    A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and losartan 50 mg/hydrochlorothiazide 12.5 mg in the treatment of moderate-to-severe essential hypertension
    Lyle, Paulette A. ; Zeldin, Robert K. ; et al.
    In: Clinical Therapeutics, Jg. 24 (2002-07-01), S. 1049-1061
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  14. Detailansicht für Treffer 14 öffnen
    Blood pressure control in patients with mild to moderate essential hypertension switched from nifedipine gastrointestinal therapeutic system (GITS) 30 mg to nifedipine GITS 20 mg
    Toal, Corey B.
    In: Clinical Therapeutics, Jg. 23 (2001), S. 87-96
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  15. Detailansicht für Treffer 15 öffnen
    The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
    Kief, Jan ; Oparil, Suzanne ; et al.
    In: Clinical Therapeutics, Jg. 18 (1996-09-01), S. 797-810
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  16. Detailansicht für Treffer 16 öffnen
    Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension
    Elkins, Michelle ; Liss, Charles ; et al.
    In: Clinical Therapeutics, Jg. 18 (1996-07-01), S. 608-625
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  17. Detailansicht für Treffer 17 öffnen
    Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension
    Boye, Sam W. ; Taylor, Addison A. ; et al.
    In: Clinical therapeutics, Jg. 31 (2009-09-30), Heft 12
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  18. Detailansicht für Treffer 18 öffnen
    Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension
    F. Wilford Germino
    In: Clinical therapeutics, Jg. 31 (2009-08-23), Heft 9
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  19. Detailansicht für Treffer 19 öffnen
    A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL)
    Coca, Antonio ; Maria Teresa Aguilera ; et al.
    In: Clinical therapeutics, Jg. 24 (2002-02-09), Heft 1
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  20. Detailansicht für Treffer 20 öffnen
    Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial
    Gazdick, Lisa P. ; Elliott, William J. ; et al.
    In: Clinical therapeutics, Jg. 23 (2001-09-18), Heft 8
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -